Michael S. Hearne serves as Executive at Odonate Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael S. Hearne has executed 112 insider transactions totaling $2.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 29, 2019 involved receiving (via award) 29 shares valued at $545.
Michael S. Hearne currently holds 10,186 shares of Odonate Therapeutics, Inc. (ODT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Hearne has been a net buyer of ODT stock. They have purchased $2.7M and sold $0 worth of shares.
Michael S. Hearne's most recent insider trade was on Mar 29, 2019, when they sold 29 shares at $18.79 per share.
Get notified when new Form 4 filings are submitted
| $20.19 |
| Discretionary |
| Feb 28, 2019 | ODT | $546 | Award | 39 | $14.01 | Discretionary |
| Feb 15, 2019 | ODT | $548 | Award | 39 | $14.04 | Discretionary |
| Jan 31, 2019 | ODT | $535 | Award | 38 | $14.08 | Discretionary |
| Jan 15, 2019 | ODT | $554 | Award | 40 | $13.85 | Discretionary |
| Dec 31, 2018 | ODT | $539 | Award | 45 | $11.97 | Discretionary |
| Dec 14, 2018 | ODT | $540 | Award | 42 | $12.85 | Discretionary |
| Dec 12, 2018 | ODT | $71.2K | Purchase | 4,550 | $15.65 | Discretionary |
| Dec 12, 2018 | ODT | $157.7K | Purchase | 10,000 | $15.77 | Discretionary |
| Dec 11, 2018 | ODT | $83.1K | Purchase | 5,450 | $15.25 | Discretionary |
| Nov 30, 2018 | ODT | $536 | Award | 40 | $13.40 | Discretionary |